Reinhart Partners’s St Jude Medical STJ Stock Holding History

Reinhart Partners’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-21,695	Closed	-$1.69M	–	111
2016 Q2	$1.69M	Sell	21,695 -300,954	-93%	-$21.5M	0.17%	64
2016 Q1	$17.7M	Buy	322,649 +26,799	+9%	+$1.46M	1.83%	31
2015 Q4	$18.3M	Buy	295,850 +53,040	+22%	+$3.35M	1.96%	24
2015 Q3	$15.3M	Buy	+242,810	New	+$17.3M	1.54%	35

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Reinhart Partners's STJ Position: Q3 2016 in Review

Reinhart Partners sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 21,695 shares — an estimated $1.69M sold.

Reinhart Partners first reported a position in STJ in Q3 2015 and held it in 4 quarters. The position peaked at $18.3M in Q4 2015. 571 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

Reinhart Partners reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
Reinhart Partners sold 21,695 St Jude Medical shares in Q3 2016, an estimated $1.69M.
Reinhart Partners first reported a position in St Jude Medical in Q3 2015 and held it in 4 quarters.
Reinhart Partners's St Jude Medical position peaked at $18.3M in Q4 2015.
571 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Reinhart Partners's 13F filing for Q3 2016, filed 19 Oct 2016.